胰腺癌腹腔灌洗液免疫细胞化学染色的临床意义
该回顾性研究纳入2002至2018年间接受胰腺切除及腹腔灌洗液细胞学检查的675例胰腺导管腺癌患者,比较术中巴氏染色快速诊断与后期免疫细胞化学染色最终诊断的结果及生存结局。研究发现最终细胞学阳性是OS的独立预后因素(HR=1.43,P=.049),而快速细胞学阳性并非独立预后因素,提示免疫细胞化学染色可作为常规巴氏染色的有用补充。
要点
- 快速细胞学阴性但最终免疫细胞化学阳性者生存显著更差(18.7 vs 34.8个月,P=.031)。
- 最终细胞学阳性是OS独立预后因素(HR=1.43,P=.049),快速细胞学阳性则不是。
- 免疫细胞化学染色可弥补快速巴氏染色假阴性,辅助胰腺癌腹腔播散评估。
核心结论
- 免疫细胞化学染色可能作为胰腺导管腺癌常规巴氏染色细胞学诊断的有用补充。
- 最终细胞学(免疫细胞化学)阳性是OS的独立预后因素(HR=1.43,P=.049)。
研究设计与样本
- 回顾性研究,纳入2002至2018年接受胰腺切除及腹腔灌洗液细胞学检查的675例胰腺导管腺癌患者。
- 同时分析术中巴氏染色快速诊断(cytology-rapid)与后期免疫细胞化学染色最终诊断(cytology-final)结果及生存结局。
主要发现
- 43例(6.4%)快速细胞学阳性,最终均为最终细胞学阳性。
- 632例快速细胞学阴性者中19例(3.0%)最终细胞学阳性。
- 快速细胞学阳性与阴性者OS差异无统计学意义(中位生存26.4 vs 32.9个月,P=.106)。
- 快速细胞学假阴性者OS显著差于真阴性者(18.7 vs 34.8个月,P=.031)。
- 最终细胞学阳性者OS显著差于阴性者(23.6 vs 34.8个月,P=.012)。
关键数值与推荐
- 快速细胞学阳性43例(6.4%),均为最终细胞学阳性。
- 快速细胞学阴性632例中19例(3.0%)最终细胞学阳性。
- 最终细胞学阳性为OS独立预后因素(HR=1.43,P=.049),快速细胞学阳性不是。
临床怎么用
- 胰腺癌切除术前腹腔灌洗液细胞学可同时行术中快速巴氏染色与后期免疫细胞化学染色。
- 对快速细胞学阴性者,免疫细胞化学最终结果有助于识别预后更差的患者,辅助术后分层管理。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 原文摘要未详细报告免疫细胞化学染色的具体方法、判读标准及围术期治疗等混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peritoneal lavage cytology for pancreatic ductal adenocarcinoma is conducted with both an intraoperative rapid diagnosis by Papanicolaou staining (cytology-rapid) and a final diagnosis by immunocytochemical staining at a later date (cytology-final) in our hospital. However, the clinical significance of cytology-final has not yet been elucidated. METHODS: A total of 675 pancreatic ductal adenocarcinoma patients who underwent pancreatectomy and cytology between 2002 and 2018 were retrospectively reviewed. Diagnostic results of cytology-rapid and cytology-final and survival outcomes were analyzed. RESULTS: A total of 43 patients (6.4%) were diagnosed as cytology-rapid (+), and all of them were ultimately diagnosed as cytology-final (+). Among the 632 patients with cytology-rapid (-), 19 (3.0%) were eventually diagnosed as cytology-final (+). The overall survival of patients with cytology-rapid (+) and that of patients with cytology-rapid (-) did not differ to a statistically significant extent (median survival time 26.4 vs 32.9 months; P = .106). In contrast, the overall survival of patients who were diagnosed as a false-negative result by cytology-rapid was significantly worse than that of patients diagnosed as a true negative (18.7 vs 34.8 months; P = .031). The overall survival of patients with cytology-final (+) was significantly worse than that of patients with cytology-final (-) (23.6 vs 34.8 months; P = .012). A multivariate analysis showed that cytology-final (+) was an independent prognostic factor for the OS (hazard ratio = 1.43; P = .049), whereas cytology-rapid (+) was not. CONCLUSION: Immunocytochemical staining may be a useful complement to a diagnosis of cytology by conventional Papanicolaou staining in pancreatic ductal adenocarcinoma patients.
引用
- Kubo H, Ohgi K, Ohike N, et al. Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer. Surgery. 2022. PMID: 36371356. doi:10.1016/j.surg.2022.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。